Electron Capital Partners LLC Trims Stock Holdings in Enovix Corporation $ENVX

Electron Capital Partners LLC lowered its holdings in Enovix Corporation (NASDAQ:ENVX) by 24.7% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 6,054,051 shares of the company’s stock after selling 1,984,345 shares during the period. Enovix comprises 2.1% of Electron Capital Partners LLC’s portfolio, making the stock its 18th largest position. Electron Capital Partners LLC owned 2.81% of Enovix worth $44,255,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Jupiter Asset Management Ltd. purchased a new position in Enovix in the third quarter valued at about $2,465,000. Granahan Investment Management LLC raised its stake in Enovix by 17.5% during the third quarter. Granahan Investment Management LLC now owns 1,749,649 shares of the company’s stock valued at $17,444,000 after buying an additional 260,085 shares in the last quarter. DNB Asset Management AS raised its stake in Enovix by 378.6% during the third quarter. DNB Asset Management AS now owns 210,748 shares of the company’s stock valued at $2,101,000 after buying an additional 166,712 shares in the last quarter. Fred Alger Management LLC raised its stake in Enovix by 9.4% during the third quarter. Fred Alger Management LLC now owns 1,442,986 shares of the company’s stock valued at $14,387,000 after buying an additional 123,814 shares in the last quarter. Finally, Blair William & Co. IL raised its stake in Enovix by 49.4% during the third quarter. Blair William & Co. IL now owns 476,450 shares of the company’s stock valued at $4,750,000 after buying an additional 157,452 shares in the last quarter. Hedge funds and other institutional investors own 50.92% of the company’s stock.

Enovix Stock Up 0.9%

Shares of Enovix stock opened at $6.69 on Thursday. The company has a current ratio of 10.97, a quick ratio of 10.65 and a debt-to-equity ratio of 2.14. The business’s 50 day simple moving average is $6.76 and its 200-day simple moving average is $6.74. The stock has a market capitalization of $1.46 billion, a price-to-earnings ratio of -8.06 and a beta of 2.27. Enovix Corporation has a twelve month low of $4.61 and a twelve month high of $16.49.

Enovix (NASDAQ:ENVX) last announced its quarterly earnings results on Wednesday, May 13th. The company reported ($0.14) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.01. The business had revenue of $7.60 million for the quarter, compared to analysts’ expectations of $6.95 million. Enovix had a negative return on equity of 64.28% and a negative net margin of 499.64%.The business’s quarterly revenue was up 49.1% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.15) EPS. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. Equities research analysts forecast that Enovix Corporation will post -0.79 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Craig Hallum cut their price objective on Enovix from $10.00 to $8.00 and set a “buy” rating on the stock in a research note on Thursday, May 14th. Wells Fargo & Company set a $6.00 price objective on Enovix in a research note on Thursday, March 12th. Bank of America assumed coverage on Enovix in a research note on Thursday, March 12th. They set a “neutral” rating and a $6.00 price objective on the stock. Wall Street Zen upgraded Enovix from a “strong sell” rating to a “sell” rating in a research note on Saturday, May 16th. Finally, Benchmark cut their price objective on Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a research note on Thursday, May 14th. Seven investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $12.64.

About Enovix

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.